SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 9.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 26.10
  • 52 Week Low: 6.27
  • Currency: UK Pounds
  • Shares Issued: 259.04m
  • Volume: 0
  • Market Cap: £25.26m

Company Listing Data

EPIC SBTX
Sector Pharma and Biotech
ISIN GB00BF33H870
Market Sector AIM
Market Segment ASQ1
Main Indices FTSE AIM All-Share
Country of register Great Britain
Currency British Pound
Market Cap £25.26m
NMS 7,500
Shares in issue 259.04m
Date Listed n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 9.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 26.10
52 Week Low 6.27
Volume 0
Shares Issued 259.04m
Market Cap £25.26m

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average
75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average
Price Trend
36.07% below the market average36.07% below the market average36.07% below the market average36.07% below the market average36.07% below the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Income Not Available
Growth
49.92% above the market average49.92% above the market average49.92% above the market average49.92% above the market average49.92% above the market average
72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average

SBTX Dividends

No dividends found

Trades for --2026

Time Volume / Share Price
0 @ 0.000p

SBTX Key Personnel

CEO Stuart Ashman
CFO Emily Bertram

Top of Page